Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)Erin L Van Blarigan, Fang-Shu Ou, Donna Niedzwiecki, et al.
Clinical Colorectal Cancer|September 17, 2013
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/AllianceJustin Jeon, Kaori Sato, Donna Niedzwiecki, et al.
The Journal of Sexual Medicine|February 22, 2023
Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinomaMarissa B Savoie, Alan Paciorek, Katherine Van Loon, et al.
The American Journal of Clinical Nutrition|July 20, 2023
Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer SurvivorsThan S Kyaw, Vaibhav Upadhyay, Irina Tolstykh, et al.
International Journal of Cancer|September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimensJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
JAMA Oncology|May 1, 2018
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance TrialErin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
Plos One|June 18, 2014
Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)Michael A Fuchs, Kaori Sato, Donna Niedzwiecki, et al.
Gastroenterology|May 27, 2014
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancerStacey Shiovitz, Monica M Bertagnolli, Lindsay A Renfro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized TrialsMarco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto, et al.
Pageof 6